Skip to main navigation
Skip to search
Skip to main content
the UWA Profiles and Research Repository Home
Login
Home
Profiles
Organisations
Research output
Grants
Datasets
Prizes / Awards
Engagement / Activities
Press/Media
Units
Equipment
Impacts
Search by expertise, name or affiliation
Pregnancy outcome following exposure to ocrelizumab in multiple sclerosis
Shin Yee Chey,
Allan G. Kermode
Research output
:
Contribution to journal
›
Article
›
peer-review
11
Citations (Web of Science)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pregnancy outcome following exposure to ocrelizumab in multiple sclerosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Multiple Sclerosis
100%
Conception
33%
Low Birth Weight
16%
Premature Labor
16%
Sepsis
16%
Congenital Malformation
16%
B Cell
16%
Infection
16%
CD20
16%
First Trimester Pregnancy
16%
Hyaline Membrane Disease
16%
Placental Insufficiency
16%
Disease Course
16%
Treatment of Multiple Sclerosis
16%
Treatment Interruption
16%
Stillbirth
16%
Monoclonal Antibody
16%
Pharmacology, Toxicology and Pharmaceutical Science
Ocrelizumab
100%
Multiple Sclerosis
100%
Infection
16%
Premature Labor
16%
Congenital Malformation
16%
Disease Course
16%
Stillbirth
16%
Placenta Insufficiency
16%
Hyaline Membrane Disease
16%
Sepsis
16%
Low Birth Weight
16%
Monoclonal Antibody
16%
Immunology and Microbiology
Multiple Sclerosis
100%
Ocrelizumab
100%
Conception
33%
B Cell
16%
Treatment of Multiple Sclerosis
16%
Monoclonal Antibody
16%
First Trimester Pregnancy
16%
CD20
16%
Low Birth Weight
16%